Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-03-11 @ 6:59 AM
Study NCT ID:
NCT01060566
Status:
COMPLETED
Last Update Posted:
2010-04-16
First Post:
2010-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX09-770-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical Monitor
Old Organization:
Vertex Pharmaceuticals Incorporated